Nutcracker Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5858 Horton St Ste 540, Emeryville, Cali...Phone Number
(415) 906-0733Website
www.nutcrackerx.comRevenue
$26.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Nutcracker Therapeutics
Nutcracker Therapeutics is a pioneering contract research, development, and manufacturing organization (CRDMO) specializing in RNA-based therapeutics for personalized medicine. The company has developed a unique end-to-end platform that addresses industry challenges in RNA design, nanoparticle delivery, and precision manufacturing. Their focus is on improving the speed, scalability, and safety of RNA therapeutic development to combat various diseases. Nutcracker Therapeutics aims to collaborate with experts to bring innovative RNA therapies to patients in need quickly.Explore more
Nutcracker Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nutcracker Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Nutcracker Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nutcracker Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nutcracker Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Nutcracker Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Nutcracker Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Nutcracker Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nutcracker Therapeutics
Product Launch: Get notified when Nutcracker Therapeutics launches new products
Recommended Actions
Find VP level buyers at Nutcracker Therapeutics
Find more new buyers
Compare Similar Companies to Nutcracker Therapeutics
Compare insights from companies similar to Nutcracker Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nutcracker Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nutcracker Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nutcracker Therapeutics.
Nutcracker Therapeutics financials insights
Gather financial insights about Nutcracker Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series B
$60M
2022
Series C
$167M
Nutcracker Therapeutics Tech Stack
A closer look at the technologies used by Nutcracker Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Executive Move
Executive Moves, Lateral Move, Board of Directors
Executive Move
Executive Moves, Board of Directors
Nutcracker Therapeutics News & Media
Nutcracker Therapeutics CEO Dr. Igor Khandros Retires as Company Continues Evolution as an RNA Therapeutics CRDMO
EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Khandros will remain on the board of directors of Nutcracker Therapeutics, and Cynthia Collins will serve as executive chair and interim CEO.Nutcracker Therapeutics Presents Precision Biomanufacturing and CRDMO Solutions at the 2024 Personalized Cancer Vaccine Summit
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nutcracker Therapeutics will introduce its CRDMO capabilities to provide scalable biomanufacturing services for RNA drug developers.Nutcracker Therapeutics Introduces CRDMO Precision Biomanufacturing Solutions for mRNA Drug Developers
EMERYVILLE, Calif.--(BUSINESS WIRE)--CRDMO capabilities are tailored for a full range of mRNA applications, including small-scale quantities for personalized cancer vaccines (PCVs).Nutcracker Therapeutics Announces Publication in ACS Nano Demonstrating the Therapeutic Viability of Nutshell® Delivery Vehicles
EMERYVILLE, Calif.--(BUSINESS WIRE)--A liver-targeted peptoid performed better than an LNP in inducing expression levels of an mRNA-encoded, anti-RSV protein in mice
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nutcracker Therapeutics
Sign Up For FreeTo access detailed company insights
Nutcracker Therapeutics is a pioneering contract research, development, and manufacturing organization (CRDMO) specializing in RNA-based therapeutics for personalized medicine. The company has developed a unique end-to-end platform that addresses industry challenges in RNA design, nanoparticle delivery, and precision manufacturing. Their focus is o... Read More
